Home/ Supplements/ Niacin/ JointAssure

JointAssure

product on market Capsule Maximum Living Safety: 96/100
96/100

This product looks safe

  • Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 33% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Glucosamine and yucca root are included for their potential to support joint health, though evidence for these effects is generally considered moderate. Niacin supports cellular energy metabolism, while other components are basic nutritional markers. Overall, the ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for JointAssure
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
40
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 {Calories}
Total Carbohydrates
1 g (1% DV)
50 mg (250% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
380 mg
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
Yucca Root
300 mg
200 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
100 mg
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
40 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews
Cayenne Pepper
20 mg

Other Ingredients

Gelatin capsule shell May include
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take two to four capsules daily.

Warnings & Precautions

Keep out of the reach of children.

Do not purchase if seal is broken.

Contains ingredients derived from shrimp and crab shell.

Formulation Notes

JointAssure was formulated to help nutritionally support cartilage and joints with Glucosamine Sulfate. JointAssure also contains other high-quality ingredients such as Yucca, Bromelain, Curcumin, Feverfew, and Niacin.

Contains ingredients derived from shrimp and crab shell.

This product contains no added sugar, yeast, corn, milk, soy, starch, or artificial colors, flavors and preservatives.

Additional Information

Store in a cool, dry place.

Please recycle this bottle when empty.

Metadata

Product Details

UPC / SKU7 88111 00021 7
DSLD Entry Date2011-12-23
Product TypeOther Combinations
FormCapsule
DSLD ID2927
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.